Clinical Trial Update: Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating camrelizumab with apatinib and capecitabine in advanced biliary tract cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)
• Capecitabine (capecitabine)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Biliary Tract Cancer, Anti-PD-1 Therapy | Phase 2 | Status: COMPLETED